The jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece?

Anu Goenka^{1

2}, Marion Roderick¹, Adam Finn^{1

2}, Athimalaipet V Ramanan^{3

4}

Affiliations

¹ Paediatric Immunology and Infectious Diseases Service, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, UK.
² Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and of Population Heath Sciences, University of Bristol, UK.
³ Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, UK.
⁴ Translational Health Sciences, University of Bristol, Bristol, UK.

Editorial

Anu Goenka et al. Rheumatology (Oxford). 2020.

. 2020 Mar 1;59(3):459-461.

doi: 10.1093/rheumatology/kez492.

Anu Goenka^{1

2}, Marion Roderick¹, Adam Finn^{1

2}, Athimalaipet V Ramanan^{3

4}

¹ Paediatric Immunology and Infectious Diseases Service, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, UK.
² Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and of Population Heath Sciences, University of Bristol, UK.
³ Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, UK.
⁴ Translational Health Sciences, University of Bristol, Bristol, UK.

No abstract available

Publication types